Medimaging Integrated Solution Inc. (TPE:6796)
Taiwan · Delayed Price · Currency is TWD 91.10
-1.80 (-1.94%)
Nov 4, 2025, 1:35 PM CST
TPE:6796 Revenue
Medimaging Integrated Solution had revenue of 154.62M TWD in the quarter ending June 30, 2025, with 26.18% growth. This brings the company's revenue in the last twelve months to 607.56M, up 23.45% year-over-year. In the year 2024, Medimaging Integrated Solution had annual revenue of 538.92M with 0.33% growth.
Revenue (ttm)
607.56M
Revenue Growth
+23.45%
P/S Ratio
5.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 538.92M | 1.77M | 0.33% |
| Dec 31, 2023 | 537.15M | 35.06M | 6.98% |
| Dec 31, 2022 | 502.09M | 16.22M | 3.34% |
| Dec 31, 2021 | 485.87M | 83.40M | 20.72% |
| Dec 31, 2020 | 402.47M | 87.97M | 27.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |